TY - JOUR 
A1 - López López, Rafael
T1 - A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)
Y1 - 2015
SN - 0732-183X
UR - http://hdl.handle.net/20.500.11940/7939
LA - eng
ER -